Influence of PRGF (Plasma Rich in Growth Factors) Puncture in Ovaries With Low Follicular Reservetechniques (PRGFO-2020)
Influence of PRGF (Plasma Rich in Growth Factors) Puncture in Ovaries With Low Follicular Reserve
Sponsor: IVI Bilbao
Terminated
Due to the difficulty in meeting the selection criteria by preventing continued recruitment to the trial. This has made recruitment more difficult and has prolonged the recruitment time to more than two years from the initially planned end of study
Other terminated trials from IVI Bilbao
More terminations from IVI Bilbao
A PHASE3 clinical study on Low Ovarian Reserve, this trial is terminated or withdrawn. The trial is conducted by IVI Bilbao and has accumulated 13 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
13 versions recorded-
Jun 2025 — Present [monthly]
Terminated PHASE3
Status: Unknown → Terminated
-
Mar 2025 — Jun 2025 [monthly]
Unknown PHASE3
Status: Recruiting → Unknown
-
Sep 2024 — Mar 2025 [monthly]
Recruiting PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE3
-
Apr 2023 — Jul 2024 [monthly]
Recruiting PHASE3
▶ Show 8 earlier versions
-
Sep 2022 — Apr 2023 [monthly]
Recruiting PHASE3
-
Sep 2021 — Sep 2022 [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
-
Jan 2021 — Sep 2021 [monthly]
Not Yet Recruiting PHASE3
-
Mar 2020 — Jan 2021 [monthly]
Not Yet Recruiting PHASE3
Status: Unknown Status → Not Yet Recruiting
-
Sep 2019 — Mar 2020 [monthly]
Unknown Status PHASE3
Status: Not Yet Recruiting → Unknown Status
-
Jun 2018 — Sep 2019 [monthly]
Not Yet Recruiting PHASE3
-
Sep 2017 — Jun 2018 [monthly]
Not Yet Recruiting PHASE3
-
Jan 2017 — Sep 2017 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- IVI Bilbao
For direct contact, visit the study record on ClinicalTrials.gov .